These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30843488)

  • 1. Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration.
    Whayne TF
    Curr Vasc Pharmacol; 2020; 18(3):254-261. PubMed ID: 30843488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.
    Goldenberg NM; Wang P; Glueck CJ
    Clin Chim Acta; 2003 Jun; 332(1-2):11-9. PubMed ID: 12763274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Oestrogens, triglycerides and pancreatitis.
    Morton A
    Aust N Z J Obstet Gynaecol; 2003 Dec; 43(6):480; author reply 480-1. PubMed ID: 14712957
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertriglyceridaemia following oestrogen use].
    Hoogerbrugge N
    Ned Tijdschr Geneeskd; 1997 Jun; 141(25):1225-7. PubMed ID: 9380163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-induced pancreatitis: a caveat worth remembering.
    Stone NJ
    J Lab Clin Med; 1994 Jan; 123(1):18-9. PubMed ID: 8288956
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Hypertriglyceridemia-Related Pancreatitis: Characteristics and Predictors of Recurrence.
    Zafrir B; Saliba W; Jubran A; Hijazi R; Shapira C
    Pancreas; 2019 Feb; 48(2):182-186. PubMed ID: 30629026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor.
    Scholz M; Tselmin S; Fischer S; Julius U
    Atheroscler Suppl; 2015 May; 18():146-53. PubMed ID: 25936319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis.
    Ivanova R; Puerta S; Garrido A; Cueto I; Ferro A; Ariza MJ; Cobos A; Gonzalez-Santos P; Valdivielso P
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):96-101. PubMed ID: 22251476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
    Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
    Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women.
    Glueck CJ; Lang J; Hamer T; Tracy T
    J Lab Clin Med; 1994 Jan; 123(1):59-64. PubMed ID: 8288962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement preparations and hypertriglyceridemia in women with NIDDM.
    Sattar N; Jaap AJ
    Diabetes Care; 1997 Feb; 20(2):234-5. PubMed ID: 9118785
    [No Abstract]   [Full Text] [Related]  

  • 15. Type and route of estrogen administration.
    Stevenson JC
    Climacteric; 2009; 12 Suppl 1():86-90. PubMed ID: 19811249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
    Murase T; Okubo M; Ebara T; Mori Y
    J Clin Lipidol; 2017; 11(6):1383-1392. PubMed ID: 28958672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are all estrogens created equal? A review of oral vs. transdermal therapy.
    Goodman MP
    J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):498-514. PubMed ID: 31060488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rare Cause of Acute Pancreatitis in a Transgender Female.
    Shipley LC; Steele DT; Wilcox CM; Burski CM
    J Investig Med High Impact Case Rep; 2020; 8():2324709620921333. PubMed ID: 32406257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.